| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 20 |
| 1 | CARBAMAZEPINE | 19 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| 3 | TACROLIMUS OINTMENT 0.1% | 16 |
| 4 | FLUDARABINE PHOSPHATE | 14 |
| 5 | MYCOPHENOLATE MOFETIL | 13 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 13 |
| 7 | CYCLOPHOSPHAMIDE | 12 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRINCIDOFOVIR | 1 | 0.0072 |
| 1 | REPOTRECTINIB | 1 | 0.0036 |
| 2 | SOYBEAN OIL | 1 | 0.0015 |
| 3 | IMIPENEM AND CILASTATIN SODIUM | 2 | 0.0009 |
| 4 | IDECABTAGENE VICLEUCEL | 1 | 0.0008 |
| 5 | TREOSULFAN | 2 | 0.0007 |
| 6 | VINORELBINE | 5 | 0.0007 |
| 7 | LETERMOVIR | 2 | 0.0006 |
| 8 | GATIFLOXACIN | 1 | 0.0006 |
| 9 | THIOTEPA | 5 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Mood Stabilizer [EPC] | 26 |
| 1 | Corticosteroid [EPC] | 20 |
| 2 | Alkylating Drug [EPC] | 16 |
| 3 | Anti-epileptic Agent [EPC] | 13 |
| 4 | Platinum-based Drug [EPC] | 11 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 6 | Kinase Inhibitor [EPC] | 10 |
| 7 | Azole Antifungal [EPC] | 9 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 5 | 0.0005 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 6 | Mood Stabilizer [EPC] | 26 | 0.0001 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |